01248nas a2200433   4500000000100000000000100001008004100002653001000043653001100053653001100064653000900075653004200084653001900126653004100145653003200186653002500218653004000243653003900283653003800322653002700360653002800387653004400415653001900459100001100478700001200489700001500501700001500516700001400531700001500545700001500560700001600575700001300591700001600604245012700620250001500747300001200762490000800774020003200782       2024                            d10aAdult10aHumans10aFemale10aMale10a*Antipsychotic Agents/therapeutic use10aCohort Studies10a*Venous Thromboembolism/epidemiology10a*Appendicitis/complications10a*Stroke/epidemiology10a*Myocardial Infarction/epidemiology10aArrhythmias, Cardiac/complications10a*Heart Failure/chemically induced10a*Dementia/drug therapy10a*Pneumonia/drug therapy10a*Acute Kidney Injury/chemically induced10a*Cholecystitis1 aP. Mok1 aM. Carr1 aB. Guthrie1 aD. Morales1 aA. Sheikh1 aR. Elliott1 aE. Camacho1 aT. Van Staa1 aA. Avery1 aD. Ashcroft00aMultiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study  a2024/04/18  ae0762680 v385  a0959-8138 (Print)
0959-8138